Similar articles

• A re-assessment of the role of combined androgen blockade for advanced prostate cancer.

  Klotz L, Schellhammer P, Carroll K. Klotz L, et al. BJU Int. 2004 Jun;93(9):1177-82. doi: 10.1111/j.1464-410x.2004.04803.x. BJU Int. 2004. PMID: 15180600 Review. No abstract available.
• [Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy].

  Suzuki K, Matsui H, Kawamura H, Ohno T. Suzuki K, et al. Gan To Kagaku Ryoho. 2015 Feb;42(2):159-63. Gan To Kagaku Ryoho. 2015. PMID: 25743135 Japanese.
• Androgen suppression plus radiation for prostate cancer.

  Millar J. Millar J. JAMA. 2004 Dec 1;292(21):2581-2; author reply 2582. doi: 10.1001/jama.292.21.2581-b. JAMA. 2004. PMID: 15572714 No abstract available.
• External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.

  Koontz BF, Lee WR. Koontz BF, et al. Arch Esp Urol. 2011 Oct;64(8):858-64. Arch Esp Urol. 2011. PMID: 22052767 Review. English, Spanish.
• External beam radiation therapy: role of androgen deprivation.

  Kupelian P. Kupelian P. World J Urol. 2003 Sep;21(4):190-9. doi: 10.1007/s00345-003-0355-y. Epub 2003 Aug 9. World J Urol. 2003. PMID: 12910363 Review. No abstract available.